consultant
clinical oncologist
with an interest in upper GI CANCERS
BEATSON WEST OF SCOTLAND CANCER CENTRE
Information pack
reF: 42057d
Closing Date:Noon on 6th May 2016
SUMMARY INFORMATION
Post: consultant clinical oncologist with an interest in head & NECK AND UPPER gi cancers
Base:BEATSON WEST OF SCOTLAND CANCER CENTRE (woscc)
Oncologist with specialist interests in Head and Neck and Upper GI cancers There will be an opportunity for successful applicants to negotiate different sub specialist interests post-appointment.
The new Beatson West of Scotland Cancer Centre (BWoSCC) opened in May 2007, completing a state of the art comprehensive cancer centre that has cost £110 million. It is Scotland’s largest cancer centre, and the second largest in the UK. The centre has undergone unprecedented investment and our clinical teams deliver oncology services to a catchment population of 2.9 million people across 4 Health Board areas. The centre is part of the CRUK virtual comprehensive cancer treatment and research centre which also includes the Beatson Institute for Cancer Research and Translational Research Centre. It incorporates the Regional Haemato-oncology Autologous Transplant Unit and the National Allogeneic Transplant Service for haematological malignancies.
The equipment in the new centre is state-of-the-art, and includes 10 linear accelerators with on board imaging, and incorporates Image Guided Radiotherapy (IGRT), IMRT, and Stereotactic Radiotherapy into our portfolio of available technologies. The centre has procured VMAT technology to more effectively deliver IMRT. A completely new brachytherapy unit and programme has been established in the new centre. A new satellite radiotherapy treatment centre is being built in nearby Lanarkshire and opened on schedule in November 2015
The Beatson is an internationally renowned academic centre, with Professors of Medical Oncology, Gyneacological Oncology, Clinical Oncology, Translational Research and Surgical Oncology currently in post. Professor Karen Vousden leads a renowned CRUK core-funded program of research at the internationally competitive Beatson Institute for Cancer Research. The clinical and research institutions are part of the virtual Comprehensive cancer Research and Treatment Centre core funded by CRUK and NHS greater Glasgow and Clyde
In addition, the Beatson West of Scotland Cancer Centre Clinical Research Unit is the largest of its kind to be funded by Cancer Research UK. The unit offers support to all clinicians within the BWoSCC to initiate and conduct first-in man clinical trials. The unit has a large portfolio of Phase I-III studies across the range of cancer sub-specialties and has a particular interest in the development of new anti-cancer drugs, supported by designated staff and facilities for Phase I/Early Phase II clinical trials. The unit also houses Scotland’s first ever co-ordinating centre for the National Cancer Research Institute.
Glasgow has excellent schools, public transport and recreational facilities.
Applicants must have full GMC Registration, a license to practise and be eligible for inclusion in the GMC Specialist Register. Those trained in the UK should have evidence of higher specialist training leading to CCT or eligibility for specialist registration (CESR) or be within 6 months of confirmed entry from the date of interview. Non-UK applicants must demonstrate equivalent training.
NHS GREATER GLASGOW & CLYDE
Consultant Clinical Oncologist
In Head and Neck and Upper GI cancers
BEATSON WEST OF SCOTLAND CANCER CENTRE
Ref: 42057D
BEATSON WEST OF SCOTLAND CANCER CENTRE
CONSULTANT CLINICAL ONCOLOGIST
TOPIC
1.Brief description of the Beatson West of Scotland Cancer Centre
- Role of the Cancer Centre
3.The work of the Directorate/Department/Specialty
4. The job Itself
5.Duties of the post
Clinical Commitments
Teaching, Management, Research and Audit
Study and Training
Research Opportunities Study and Training Research Opportunities Provisional Weekly Timetable
6.Arrangements to visit the Cancer Centre
7.Person Specification Oncologist
- Term & Conditions of Service
9. Further Information
BEATSON WEST OF SCOTLAND CANCER CENTRE
Further Particulars of the Post of Consultant Oncologist
Based initially atBeatson West of Scotland Cancer Centre site.
1. Description of the Beatson West of Scotland Cancer Centre
The Beatson West of Scotland Cancer Centre (BWoSCC) is Scotland’s largest cancer centre, and the largest in the UK based on activity. The centre has undergone unprecedented capital and resource investment and our clinical teams are redesigning the way oncology services are delivered to a population of 2.9m people across four Health Board areas. It offers our team of professionals a truly state-of–the-art environment in which to practise and develop their skills.
An internationally-renowned teaching centre, the Cancer Centre incorporates the academic units of Medical Oncology, Radiation Oncology, Translational Research and Palliative Care. Glasgow is a large, lively and friendly city and a great place to make a home. The schools are excellent and many are local to the cancer centre. In addition it has excellent transport links to other parts of Scotland, the UK and beyond. The city was host to the Commonwealth Games in summer 2014.
- Role of the Cancer Centre
The role of the Cancer Centre is to deliver all non-surgical oncology services for residents of the West of Scotland on the basis that:
services meet equitably the assessed needs of the population served
a high quality service, integrated within the Cancer Centre and also with other cancer care providers, is provided
services provided compare favourably with those elsewhere in the UK and there is continual focus on improving care and treatment for patients
expenditure represents value for money
staff are valued and encouraged to maintain high standards of patient care through, for example, access to continuing professional development
clinical outcomes are monitored and are discussed in the context of clinical audit and clinical governance
research and development are encouraged
3.The Work of the Cancer Centre
The Beatson West of Scotland Cancer Centre provides specialist oncology services to 60% of the Scottish population. The centre sees over 10,000 new patients a year and over 70,000 return patients. Over 105,000 fractions of radiotherapy and 28,000 cycles of chemotherapy are given each year in the centre alone. The clinical teams also deliver
medical cancer treatments in 13 local hospitals in partnership with local specialist cancer teams. The centre employs over 800 staff including 75 consultants in oncology and haematology. The annual budget of Specialist Oncology Services is over £100m.
The centre has 170 beds in 9 wards (3 Wards of 40 beds are for haemato-oncology). One of these wards runs as an 8 bedded Brachytherapy Unit and one as an 18 bed 5 day/week chemotherapy ward. There is also a large and busy Day Case Chemotherapy Unit comprising 36 treatment stations. The centre has a self contained Acute Oncology Assessment Unit staffed by Advanced Nurse Practitioners which provides unscheduled care for cancer patients on treatment. The centre has its own out-patient department and a large aseptic facility for cytotoxic reconstitution. The unit has an accredited gene therapy aseptic facility. Up to 10 appropriate patients are accommodated in a local hotel while they undergo radiotherapy. The Beatson West of Scotland Cancer Centre (BWoSCC) is superbly equipped with 10 linear accelerators, the majority of which incorporate facilities for VMAT and on-board imaging (OBI).We continue to install state-of-the-art Varian TrueBeamTM units through the Capital Equipment Replacement Programme (CERP) utilising Scottish Government funded ring fenced monies. These facilities have allowed a dynamic, “can-do” approach to the development of new treatment techniques. The centre has launched high intensity mode (24 Gy/min) VMAT for stereotactic intracranial radiosurgery and for lung stereotactic ablative radiotherapy (SABR), both firsts for the UK. In addition, VMAT has become a well established routine treatment for all radical head and neck, brain and prostate.
VMAT has become the treatment of choice at the centre for most radicalradiotherapy treatments within the last 12 months.There are exciting programmes underway to continue to develop the technique for gynaecological, colo-rectal, lung treatment and prostate SABR. Supporting these developments is an expanding IGRT programme with facilities for CBCT, 4DCT, on-site MRI and PET/CT. 4DCT imaging is offered routinely for lung, and, driven by local clinical interest, will shortly be introduced for pancreas and breast. Imaging is supported by 3 CT Simulators and 1 conventional simulator.
A satellite unit opened on schedule in November 2015 at the Lanarkshire Beatson site.This facility augments our radiotherapy capacity with 2 further TrueBeam LINACS with full planning and mould room capability.The Lanarkshire Beatson is located 20 miles to the east of the parent centre.
The centre has a generously equipped brachytherapy facility with dedicated theatre and 2 HDR treatment units. On-site MRI is used to facilitate imaged-guided brachytherapy for cervix. There is an established LDR seed programme for prostate.
There is excellent access to CT, CT-PET and MRIscanning facilities for radiation planning, both in the Cancer Centre and in the adjacent West of Scotland Pet Centre. A second CT-PET scanner has been installed in June 2011. The WestGlasgowHospitals and many of the District General Hospitals throughout the Region are equipped with digital communication links and can transmit CT scan images to the centre. There is excellent co-operation with the Regional Department of Clinical Physics and Bio-Engineering whose headquarters are at the Western Infirmary. The Radiotherapy Division is based in the Cancer
Centre. A large program of research and development in radiation physics has been developed, including research fellows and research physicists. The Radiotherapy Research Group and its program are led by Professor Anthony Chalmers.
National services at the Cancer Centre include sarcoma, prostate brachytherapy, allogeneic stem cell transplantation, and ophthalmic oncology. The Cancer Centre offers the full range of evidence-based regional oncology services including CHART therapy for lung cancer.
The Cancer Centre is an internationally renowned academic centre, with Professors of Clinical Oncology, Translational Research and Gynaecological Oncology currently in post. Professor Karen Vousden heads the laboratories at the internationally renowned Beatson Institute for Cancer Research, located 3 miles from the centre. This initiative, developed in collaboration with Cancer Research UK, offers unrivalled opportunity for collaboration in basic cancer research. The Beatson Institute has undergone a £30 million redevelopment funded by Cancer Research UK and the University of Glasgow. A Translational Research Centre has recently been built on the Garscube Estate to complete a virtual comprehensive cancer research and treatment centre, given CRUK Centre status in 2011. The Cancer Sciences Division was 4th in the whole of the United Kingdom in the 2009 Research Assessment Evaluation
For the Cancer Centre as a whole, there are particularly close links with the academic departments in GlasgowUniversity of gynaecology, surgery, pathology, dermatology and ophthalmology. These involve several joint clinics as well as clinical research projects. Close links also exist with CaledonianUniversity (therapy radiography), StrathclydeUniversity and PaisleyUniversity (radiation physics).
In addition, the Clinical Research Facility at the BWOSCC is the largest of its kind to be funded by Cancer Research UK. It houses Scotland’s first ever co-ordinating centre for the National Cancer Research Institute. The unit offers support to all clinicians within the BWOSCC to initiate and conduct clinical trials. The unit has a large portfolio of Phase I - III studies across the range of cancer sub-specialties and has a particular interest in the development of first-in-man anti-cancer
drugs. It is supported by designated staff and facilities for Phase I/early Phase II clinical trials. The trials unit has been rated alpha-star by external review. Already, at least 11% of the regional cancer centre’s patients are entered into clinical trials.
Clinics are held in eight hospitals within NHS Greater Glasgow & Clyde and in seven in other board areas. Chemotherapy is prescribed and delivered in nine hospitals outwith the city of Glasgow.
In 2013 the centre opened a new Acute Oncology Assessment Unit to provide on site specialist triage and assessment of cancer patients with unscheduled needs. Thus unit is staffed by 2 Advanced Nurse Practitioners and 4 senior triage nurses 8-8pm Monday to Friday. In May 2015 we opened a 4 bed High Acuity Unit staffed by Critical Care nurses who also facilitate an outreach service throughout the centre for medically deteriorating patients.
4.The Job Itself
(a)Title:Consultant Clinical Oncologist
NHS Greater Glasgow & Clyde is the employing authority.
The Names of current consultant members of the Service are:
Clinical Oncology
Dr David Dodds (Clinical Director)
Dr Diana Ritchie Dr Diana Ritchie
Professor Anthony ChalmersDr Stefano Schipani
Dr Richard D JonesDr Azmat Sadoyze
Dr Fiona Cowie Dr Nick Reed
Dr Allan JamesDr Claire Paterson
Dr Rosemary StevensDr Nazia Mohammed
Dr Alec McDonaldDr Jan Wallace
Dr Ghislaine Fraser Dr Carrie Featherstone
Dr Abdulla Alhasso Dr Aisling Hennessy
Dr Jonathan HicksDr David Macintosh
Dr Mohammed RizwanullahDr Vivienne MacLaren
Dr Rosie HarrandDr Graeme Lumsden
Dr Stephen HarrowDr Grainne Dunn
Dr Norma SidekDr Carolynn Lamb
Dr Brian ClarkDr Derek Grose
Dr Noelle O’RourkeDr Nick MacLeod
Dr Kathryn Graham
Medical Oncology
Dr David Dunlop(Chief of Medicine Regional Services)
Dr Ros Glasspool
Dr Rob Jones Dr Hilary Glen
Professor T R Jeff Evans Dr Iain Macpherson
Dr Jeff WhiteDr Sophie Barrett
Dr Judy Fraser Dr Lucy Scott
Dr Ashita WaterstonDr Nicola Steele
Dr Clinton AliDr Janet Graham
Dr Dawn StoreyProf. Iain McNeish
Dr Balaji Venugopal
Palliative Medicine
Dr Alison Mitchell
Dr Jane Edgecombe
Dr Helen Morrison
Number and Grades of Junior Medical Staff
“Specialist Registrars” 19 in Clinical Oncology + 5 in Medical Oncology
Specialty Trainees 15
Associate Specialist in Oncology 1
Speciality Doctors 5
Departmental Organisation
In order to facilitate medical management the BWOSCC is divided into 6 teams for specialist oncology services based on the following tumour sites:
Breast
Lung
Urology
GI
Head & Neck (& neuro-oncology)
Gynaecology (including neuro endocrine and sarcoma)
All wards within the BWOSCC (with the exception of brachytherapy) are allocated to the teams and have integrated medical and clinical oncology stakeholders. There are 2 Consultant on-call rotas, one for Medical Oncology and one for Clinical Oncology. On call commitments take priority over scheduled commitments when consultant on call.The BWOSCC is committed to multi-disciplinary team working and the Cancer Managed Clinical Networks for the West of Scotland.
Each team has a trainer who supervises the trainees. Clinical and Educational Supervision is provided to trainees in conjunction with the local Deanery. The teams are headed by a team leader who is responsible for the development of departmental medical protocols, absence management and team deployments.
All consultants participate in care delivered by multidisciplinary cancer site specific teams consisting of Specialty Doctors, Clinical Nurse Specialists, IV Nurses, Pharmacists and Phlebotomists. All beds are shared and managed by a Bed Management Team who arranges admissions on the basis of need. The centre has a 6 bedded state of the art, age appropriate Teenage and Adolescent Unit which is used by patients between the ages of 16 and 25 with solid and haematological cancers.
5.Duties of the Post
Clinical Commitments:
This is a new consultant appointment. The successful applicant will take up a post providing specialist oncology input into upper GI cancer services in Argyll and Clyde and Regional Head and Neck services linked to MDTs in either the North or South of the city.These services are mature, developed and supported by teams of existing consultant clinical and medical oncologists. These practices involve participation in well organised and supported site specific MDTs locally and regionally.
This job plan is negotiable and will be agreed between the successful applicant and the Clinical Director. NHS Greater Glasgow & Clyde initially allocates all full time consultants 10 PAs made up of 9 PAs in Direct Clinical Care (DCC) and one core Supporting Professional Activities (SPA) for CPD, audit, clinical governance, appraisal, revalidation, job planning, internal routine communication and management meetings. The precise allocation of SPA time and associate objectives will be agreed with the successful applicant and will be reviewed at annual job planning.
A proposed timetable for the post is detailed below. Note that this post is for a commitment of 10 sessions (PAs) initially. Most consultant posts with significant peripheral commitments will generally attract an additional PA for travel time. The number of PAs can vary with service activity and is agreed through the job planning process.
Monday AM / am / Head and Neck MDT/OP Clinic Glasgow Royal Infirmarypm / Head and Neck ward round BOC/Admin
Tuesday / am / Radiotherapy Voluming
pm / Clinical Admin/SPA
Wed / am / Upper GI MDT/Ward Round/Peer review meeting
pm / Upper GI clinic BOC
Thursday / am / HepatoBiliary MDT Glasgow Royal Infirmary
pm / Head and Neck pre-assessment clinic/Head and Neck radiotherapy Peer review meeting
Friday / am / Radiotherapy Simulator
pm / Teaching/SPA
Radiotherapy is delivered in the Beatson West of Scotland Cancer Centre.
There will be an option for remote radiotherapy planning from Glasgow to deliver therapy at the new satellite centre in Monklands Hospital for lanarkshire patients.
Cross cover is provided by named colleagues. Note that the post holder works as part of a team to manage cross cover for clinics and radiotherapy planning. It is anticipated that the successful applicant will be a member of the relevant site specific teams.
The on call frequency is 1 week on call in 28. When on call the consultant is expected to reduce/cancel scheduled off site clinical activities to participate in on call duties and the review of unscheduled admissions